Importantly, this phenotype could be recapitulated in BRCA1/2-deficient cancer cell lines (Dréan et al., 2017) (Figures 7D, 7E, S6G, and S6H) and is dependent on the nuclease activity of EXD2 (Figures 7F and S6I). The gene discussed is BRCA1; the disease is cancer.